What Is Phenoconversion? When Your Medications Override Your Genes

Phenoconversion is a mismatch between your genotype and your phenotype. Your genotype is the DNA you were born with. Your phenotype is how your body actually behaves, in this case how fast a metabolizing enzyme like CYP2D6 or CYP2C19 clears a drug. Most of the time they line up: if your genes code for a normal CYP2D6 enzyme, you metabolize CYP2D6 drugs at a normal rate. But some medications block or speed up these enzymes. When you take one, your enzyme can behave like a different genotype entirely. A person born a normal metabolizer can temporarily function as a poor metabolizer. Their DNA has not changed; another drug is holding the enzyme down.^[1] That shift is phenoconversion, and it is the single biggest reason a genetic test result is not the whole story.

Many common drugs are enzyme inhibitors. They occupy or block a metabolizing enzyme so it cannot do its normal job on other medications. The strength matters. Clinical guidelines sort inhibitors into strong, moderate, and weak.^[2] A strong CYP2D6 inhibitor like fluoxetine, paroxetine, or bupropion can knock the enzyme's effective activity all the way to zero, converting a normal metabolizer into a functional poor metabolizer. A moderate inhibitor roughly halves the activity, which is often enough to push a normal metabolizer down into the intermediate range.^[1] Weak inhibitors are flagged but usually do not move you into a different category on their own.

The opposite can also happen. Some drugs, such as rifampin, carbamazepine, and St. John's wort, are enzyme inducers. They prompt your body to make more of an enzyme, so it clears certain drugs faster than your genes alone would predict. An induced enzyme can make a normal metabolizer behave more like a rapid one, which can drop drug levels below the range where they work. Induction usually builds over a week or two rather than overnight, and it fades over a similar window after the inducer stops.

Pharmacogenetics translates your genotype into an activity score, a number that summarizes how much working enzyme you have. That score maps onto a phenotype: poor, intermediate, normal, rapid, or ultrarapid metabolizer. Phenoconversion is applied to the score. A strong inhibitor sets the effective score to zero. A moderate inhibitor multiplies it by one half.^[1] The recalculated score lands you in a new phenotype band, and the right dosing guidance is the guidance for that effective phenotype, not the one printed on your original report.

Phenoconversion hides in plain sight because each drug, looked at alone, may be perfectly appropriate for you. The problem only appears in combination, and only if someone is tracking the whole list at once. A genetic report is a snapshot of your DNA on the day it was run. It cannot know what you started taking last month. That gap between a fixed report and a changing medication list is where phenoconversion arises.

Phenoconversion is most consequential on the enzymes that handle the widest range of common drugs. These are the same pharmacogenes a Gene2Rx report calls from your DNA. The genotype is what you start with; the medications you take determine the effective phenotype on top of it.

A Gene2Rx report assigns you a metabolizer phenotype for each of these genes from your DNA, anchored to CPIC and FDA guidelines.^[6] That genotype-based phenotype is the correct starting point and it never changes. What changes is the effective phenotype once your medications are layered on. Reading your effective phenotype means combining your fixed genotype with your current, real medication list, and recomputing whenever that list changes.

Knowing your baseline metabolizer status is the foundation, because you cannot recognize a metabolism shift if you do not know where you started. Pharmacogenetic testing is most useful if you take more than one medication, if you have started a new drug and an existing one suddenly feels stronger or weaker, or if you have had side effects or poor response that no one could explain. Once you know your genotype, the next question is what your current medications are doing to it.

• Can Two Safe Medications Be Dangerous Together? How Metabolism Interactions Work
• Medications That Cause Phenoconversion: The Common Enzyme Inhibitors
• 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
• AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data
• MyHeritage Pharmacogenetics: Use Your MyHeritage DNA for a Drug Response Report
• Nebula Genomics Pharmacogenetics: How to Get a Drug Response Report From Your WGS Data

No. Phenoconversion lasts only as long as the drug causing it is in your system. When you stop a strong inhibitor, your enzyme returns to its genetic baseline over the following days as the drug clears, though some inhibitors and most inducers take longer to wash out. Your genotype itself never changes; only the effective phenotype shifts.

No. Your genetic test reports your genotype-based phenotype, which is accurate and fixed for life. Phenoconversion is a separate layer on top of it caused by your medications. A good genetic result plus an up-to-date medication list is what gives you your true effective phenotype at any moment.

CYP2D6 is the classic example, because several common antidepressants are strong CYP2D6 inhibitors. CYP2C19, CYP3A4, and CYP2C9 are also frequently affected. These are the same enzymes that handle a large share of psychiatric, cardiac, and pain medications, which is why phenoconversion has such broad clinical reach.

You usually cannot tell from symptoms alone, which is what makes it tricky. The clues are timing, such as an existing medication feeling suddenly stronger or weaker after you start something new, or unexpected side effects from a drug you tolerated before. Tracking your full medication list against your genotype is the reliable way to catch it, and is exactly what the Gene2Rx app is built to do.